A phase 2, double-blind, placebo-controlled trial of a valproate/lithium combination in ALS patients

Background: Few treatments are currently available for amyotrophic lateral sclerosis (ALS). A combination of lithium carbonate and valproic acid (VPA-Li) was shown to inhibit motor neuron death and delay disease progression. Methods: Outpatients with a typical ALS presentation were enrolled in a ran...

Cijeli opis

Bibliografski detalji

Glavni autori:	M.-C. Boll, M. Alcaraz-Zubeldia, C. Rios, D. González-Esquivel, S. Montes
Format:	Artigo
Jezik:	Espanhol
Izdano:	Elsevier España 2025-01-01
Serija:	Neurología
Teme:	Esclerosis lateral amiotrófica Ensayo clínico Doble ciego Tratamiento sinérgico Neuroprotección
Online pristup:	http://www.sciencedirect.com/science/article/pii/S0213485322000779
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!